Cognitive therapy and generalized anxiety disorder
Not Applicable
- Conditions
- Generalized Anxiety Disorder.Generalized anxiety disorder
- Registration Number
- IRCT138806282482N1
- Lead Sponsor
- niversity of wellbeing science rehabilitation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 3
Inclusion Criteria
1.not having a prior psychological intervention 2. having at least diploma 3. not having severe personality disorders. Exclusion criteria: 1.psychopharmachotherapy 2.psychosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Worry & worry domains. Timepoint: weekly. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Schema. Timepoint: 5 months. Method of measurement: questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie schema therapy's efficacy in generalized anxiety disorder?
How does schema therapy compare to CBT in treating women with generalized anxiety disorder?
Are there specific biomarkers that predict response to schema therapy in anxiety disorders?
What are the potential adverse events associated with schema therapy for anxiety treatment?
What combination approaches enhance schema therapy outcomes in generalized anxiety disorder?